Corrigendum to 'Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study' [Respir Investig 64/5 (2026) 101503].
- DOI
- 10.1016/j.resinv.2026.101517
- Published
- 2026-10-12
- Container
- Respir Investig
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.resinv.2026.101517,
title = {Corrigendum to 'Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study' [Respir Investig 64/5 (2026) 101503].},
author = {Ota H and Sogabe S and Murakami Y and Uchida K and Kawabata T and Hiramatsu Y and Sakabe M and Cho K and Yamamoto R and Ooi R and Sugimoto T and Yoshimine K and Nishizawa S and Ide H and Hanaka M and Tobino K.},
year = {2026},
journal = {Respir Investig},
doi = {10.1016/j.resinv.2026.101517},
url = {https://doi.org/10.1016/j.resinv.2026.101517}
}RIS
TY - JOUR TI - Corrigendum to 'Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study' [Respir Investig 64/5 (2026) 101503]. AU - Ota H AU - Sogabe S AU - Murakami Y AU - Uchida K AU - Kawabata T AU - Hiramatsu Y AU - Sakabe M AU - Cho K AU - Yamamoto R AU - Ooi R AU - Sugimoto T AU - Yoshimine K AU - Nishizawa S AU - Ide H AU - Hanaka M AU - Tobino K. PY - 2026 JO - Respir Investig DO - 10.1016/j.resinv.2026.101517 UR - https://doi.org/10.1016/j.resinv.2026.101517 ER -
APA
H, O., S, S., Y, M., K, U., T, K., Y, H., M, S., K, C., R, Y., R, O., T, S., K, Y., S, N., H, I., M, H., & K., T. (2026). Corrigendum to 'Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study' [Respir Investig 64/5 (2026) 101503].. Respir Investig. https://doi.org/10.1016/j.resinv.2026.101517
Source records
- europe-pmc · retrieved 2026-11-10T13:34:36.324Z